Table 2.
Maternal and neonatal characteristics in postscreening EOGBS cases
| Characteristics | Prescreening (2013) (n=8) |
Screening (2014, 2015) (n=3) |
Postscreening April 2016-Mar 2017 (n=9) |
| Neonatal | |||
| Sex (M/F) | 3/5 | 2/1 | 7/2 |
| Gestational age range (weeks) | 25–41 | 38–41 | 39–42 |
| Age (days) range at time of detection of infection | 0–6 | 0–6 | 0–6 |
| Group B streptococcus bacteraemia | 8 | 2 | 9 |
| Meningitis | 0 | 1 | 0 |
| Fatality | 0 | 0 | 1 |
| Maternal | |||
| Preterm Premature rupture of membranes | 0 | 0 | 0 |
| Intrapartum fever | 1 | 0 | 0 |
| Group B Streptococcus In urine |
0 | 0 | 0 |
| Previous Group B streptococcus infected baby |
0 | 0 | 0 |
| Antepartum Group B Streptococcus in High vaginal swab* | 0 | 0 | 1* |
| Prolonged rupture of membranes (≥12 hrs)† | 1 | 0 | 5 |
One of the term babies died of severe septicaemia secondary to the EOGBS infection.
*Intrapartum antibiotic prophylaxis not given.
†Not a risk factor in RCOG and NICE guidelines (2012).
EOGBS, early-onset group B Streptococcus; NICE, National Institute for Health and Care Excellence; RCOG, Royal College of Obstetricians and Gynaecologists.